Enno Spillner

Enno was appointed as the new Chief Financial Officer and as a member of the Executive Board of Evotec SE in July 2016. In addition to the traditional Financial Operations, his responsibilities include the operations of IT, Legal, Supply Chain Management and Procurement as well as Risk Management. Moreover, he is involved in Investor Relations Management.

From April 2013 to June 2016, he was CEO and CFO of the listed 4SC AG based in Martinsried. From September 2005 he was a member of the company’s Executive Board responsible for Finance and further administrative areas, and was involved in listing 4SC AG on the stock exchange. Before that, since the beginning of 1999, Enno had been working at Bio^M AG, initially as Head of Finance & Controlling. Later, he was responsible for substantial parts of the Investment Business of Bio^M, in addition to the Financial Operations. In this context, he also held interim positions as CFO or CEO in portfolio companies, including that of interim managing director of ACTIPAC Biosystems GmbH and of Munich Innovative Biomaterials GmbH. In September 2001, as a partner, he also managed the business of the Bio^M VC Fund. Enno started his professional career as an assistant to the management of MediaPlus Spezialagentur für Media GmbH (ServicePlan Group) based in Munich.

Since 2014 he has been a Non-Executive Member of the Board of Directors and the chairman of the Audit Committee of Nanobiotix SA, Paris, which is listed on EURONEXT.

Enno is a graduate in business administration from the University of Bamberg.